Back
  1. Home
  2. Profile of Pierre Freres (ULiège)
Profil

Freres Pierre

Département des sciences cliniques

See author's contact details
Main Referenced Co-authors
Jerusalem, Guy  (23)
Bours, Vincent  (14)
Josse, Claire  (14)
Collignon, Joëlle  (9)
Poncin, Aurélie  (9)
Main Referenced Keywords
breast cancer (10); oncology (5); cancer (4); Humans (4); Medicine (all) (4);
Main Referenced Unit & Research Centers
Giga-Cancer - ULiège [BE] (5)
GIGA‐R - Giga‐Research - ULiège [BE] (2)
Giga-Genetics - ULiège [BE] (2)
Main Referenced Disciplines
Oncology (26)
Genetics & genetic processes (4)
Neurology (2)
Cardiovascular & respiratory systems (1)
General & internal medicine (1)

Publications (total 33)

The most downloaded
2586 downloads
FRERES, P., GONNE, E., COLLIGNON, J., GIOT, J.-B., GENNIGENS, C., & JERUSALEM, G. (2015). Prise en charge de la neutropénie fébrile chez le patient cancéreux. Revue Médicale de Liège, 70 (4), 195-200. https://hdl.handle.net/2268/184322

The most cited

128 citations (Scopus®)

Bovy, N., Blomme, B., Freres, P., Dederen, S., Nivelles, O., Lion, M., Carnet, O., Martial, J., Noël, A., Thiry, M., Jerusalem, G., Josse, C., Bours, V., Tabruyn, S., & Struman, I. (2015). Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget. doi:10.18632/oncotarget.3520 https://hdl.handle.net/2268/181499

Streel, S., Kirkove, D., Seidel, L., Rorive, A., Freres, P., Gennigens, C., Sibille, A., PAULUS, A., Gagnayre, R., Pétré, B., & Jerusalem, G. (2024). Beyond Information: Revealing Alarming Decision-Making Results in Coping with Immune-Related Adverse Events through Hypothetical Scenarios An illustration through the Immuno’Act© acceptance study. Belgian Journal of Medical Oncology.
Peer Reviewed verified by ORBi

Sacher, A., LoRusso, P., Patel, M. R., Miller, W. H., Garralda, E., Forster, M. D., Santoro, A., Falcon, A., Kim, T. W., Paz-Ares, L., Bowyer, S., de Miguel, M., Han, S.-W., Krebs, M. G., Lee, J.-S., Cheng, M. L., Arbour, K., Massarelli, E., Choi, Y., ... Freres, P. (Other coll.). (24 August 2023). Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation. New England Journal of Medicine, 389 (8), 710 - 721. doi:10.1056/NEJMoa2303810
Peer Reviewed verified by ORBi

Lambert, N., El Moussaoui, M., & FRERES, P. (10 November 2021). Prise en charge multidisciplinaire de la leucoencéphalopathie multifocale progressive [Paper presentation]. Grandes cliniques intégrées du CHU de Liège.

ONESTI, C. E., Schroeder, H., Rorive, A., Sautois, B., Lecocq, M., Goffin, M., Gonne, E., Collinge, A., Nicolaers, L., Wéra, O., Catot, A., Loly, C., Paulus, A., Sibille, A., Lousberg, L., Troisfontaine, F., Collignon, J., Gennigens, C., Frères, P., ... Jerusalem, G. (2021). Oncological patients' reactions to COVID-19 pandemic: A single institution prospective study. Cancer Reports, 1571. doi:10.1002/cnr2.1571
Peer reviewed

Uyisenga, J. P.* , Debit, A.* , Poulet, C., Frères, P., Poncin, A., Thiry, J., Mutesa, L., Jerusalem, G., Bours, V.* , & JOSSE, C.*. (03 June 2021). Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites. Scientific Reports, 11 (1), 11698. doi:10.1038/s41598-021-91278-0
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Martin, D., Bianchi, E., Ben Mustapha, S., & Freres, P. (May 2021). Le glioblastome. Revue Médicale de Liège, 76 (5-6), 419 - 424.
Editorial Reviewed verified by ORBi

Debruche, M., Mettlen, C., PAULUS, A., VAILLANT, F., Sibille, A., Freres, P., Duysinx, B., & Louis, R. (May 2021). Cancer pulmonaire non à petites cellules chez les patients non fumeurs au CHU de Liège : étude rétrospective entre début 2017 et fin 2018. Revue Médicale de Liège, 76 (5-6), 446 - 451.
Editorial Reviewed verified by ORBi

Freres, P., Poncin, A., & Lecocq, M. (May 2021). Les manifestations indésirables liées à l’immunothérapie. Revue Médicale de Liège, 76 (5-6), 403 - 407.
Editorial Reviewed verified by ORBi

Denis, C., Sakalihasan, S., FRERES, P., WITHOFS, N., & SAUTOIS, B. (2021). Cemiplimab for cisplatin resistant metastatic penile cancer. Case Reports in Oncology, 14, 972-976. doi:10.1159/000517008
Peer Reviewed verified by ORBi

ONESTI, C. E., SCHROEDER, H., RORIVE, A., SAUTOIS, B., LECOCQ, M., Goffin, M., GONNE, E., COLLINGE, A., NICOLAERS, L., WERA, O., Catot, A., LOLY, C., PAULUS, A., SIBILLE, A., LOUSBERG, L., Troisfontaine, F., COLLIGNON, J., GENNIGENS, C., FRERES, P., & JERUSALEM, G. (2020). How do oncological patients perceive the Covid-19 (SARS-CoV-2) pandemic ? Experience from CHU Liege in Belgium [Poster presentation]. ESMO Virtual Congress 2020, Madrid, Spain.

LECOCQ, M., ONESTI, C. E., SCHROEDER, H., RORIVE, A., Goffin, M., GONNE, E., SAUTOIS, B., Catot, A., WERA, O., NICOLAERS, L., COLLINGE, A., Collignon, J., FRERES, P., POLUS, M., DUYSINX, B., VAILLANT, F., GENNIGENS, C., MARCHAL, N., PONCIN, A., & JERUSALEM, G. (2020). Risk of SARS-CoV-2 infection and outcome after infection : Experience from the day-care unit at CHU Liege in Belgium [Poster presentation]. ESMO Virtual Congress 2020, Madrid, Spain.

ONESTI, C. E., FRERES, P., & JERUSALEM, G. (2019). Atypical patterns of response to immune checkpoint inhibitors: interpreting pseudoprogression and hyperprogression in decision making for patients’ treatment. Journal of Thoracic Disease. doi:10.21037/jtd.2018.12.47
Peer Reviewed verified by ORBi

ONESTI, C. E., JOSSE, C., Poncin, A., FRERES, P., Poulet, C., BOURS, V., & JERUSALEM, G. (2018). Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment. Oncotarget. doi:10.18632/oncotarget.26120
Peer Reviewed verified by ORBi

ONESTI, C. E., JOSSE, C., PONCIN, A., FRERES, P., Poulet, C., BOURS, V., & JERUSALEM, G. (13 September 2018). Predictive and prognostic role of peripheral blood eosinophil count in triple negative and hormone receptor negative/HER2 positive breast cancers patients undergoing neoadjuvant treatment [Paper presentation]. GIGA-Cancer Day 2018 / EDT-Cancerology Vascular landscape and (pre)metastatic niche in cancer biology.

FRERES, P. (2018). Les rôles des micro-ARN circulants dans le cancer du sein [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315030

Freres, P., Bouznad, N., Servais, L., JOSSE, C., Wenric, S., Poncin, A., Thiry, J., Moonen, M., Oury, C., Lancellotti, P., Bours, V., & Jerusalem, G. (2018). Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients. BMC Cancer, 18 (1). doi:10.1186/s12885-018-4015-4
Peer Reviewed verified by ORBi

FRERES, P., GENNIGENS, C., Martin, D., & Jerusalem, G. (October 2017). Leptomeningeal carcinomatosis from solid tumours : a systematic review of the literature. Belgian Journal of Medical Oncology, 11, 259-264.
Peer Reviewed verified by ORBi

Wenric, S., El Guendi, S., CABERG, J.-H., Bezzaou, W., Fasquelle, C., Charloteaux, B., Karim, L., Hennuy, B., FRERES, P., COLLIGNON, J., BOUKERROUCHA, M., SCHROEDER, H., Olivier, F., Jossa, V., JERUSALEM, G., JOSSE, C., & BOURS, V. (May 2017). Transcriptome wide analysis of natural antisense transcripts shows potential role in breast cancer [Poster presentation]. 50th meeting of the European Society of Human Genetics, Copenhagen, Denmark.

Wenric, S., ElGuendi, S., CABERG, J.-H., Bezzaou, W., Fasquelle, C., Charloteaux, B., Karim, L., Hennuy, B., FRERES, P., COLLIGNON, J., BOUKERROUCHA, M., SCHROEDER, H., OLIVIER, F., Jossa, V., Jerusalem, G., JOSSE, C., & Bours, V. (2017). Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer. Scientific Reports, 7 (1), 17452. doi:10.1038/s41598-017-17811-2
Peer Reviewed verified by ORBi

FRERES, P., LOUSBERG, L., & JERUSALEM, G. (July 2016). Cyclin-dependent protein kinase inhibitors in breast cancer treatment. Belgian Journal of Medical Oncology, 10 (4), 132-138.
Peer Reviewed verified by ORBi

FRERES, P., PONCIN, A., MOONEN, M., Josse, C., Oury, C., BOURS, V., LANCELLOTTI, P., & JERUSALEM, G. (2016). La cardiotoxicité des traitements anti-cancéreux. Revue Médicale de Liège, 71 (9), 382-387.
Peer reviewed

Freres, P.* , Wenric, S.* , BOUKERROUCHA, M., Fasquelle, C., Thiry, J., Bovy, N., Struman, I., Geurts, P., COLLIGNON, J., SCHROEDER, H., KRIDELKA, F., LIFRANGE, E., Jossa, V., Bours, V.* , Josse, C.* , & JERUSALEM, G.*. (2015). Circulating microRNA-based screening tool for breast cancer. Oncotarget. doi:10.18632/oncotarget.6786
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Boukerroucha, M., Josse, C., SEGERS, K., El Guendi, S., FRERES, P., JERUSALEM, G., & Bours, V. (26 March 2015). BRCA1 germline mutation and glioblastoma development: report of cases. BMC Cancer, 15, 181. doi:10.1186/s12885-015-1205-1
Peer Reviewed verified by ORBi

Boukerroucha, M., Josse, C., El Guendi, S., FRERES, P., Marée, R., Wenric, S., SEGERS, K., COLLIGNON, J., JERUSALEM, G., & BOURS, V. (2015). Genetic study of triple negative breast cancers [Poster presentation]. Impakt Breast Cancer Conference, Brussels, Belgium. doi:10.1093/annonc/mdv116.11

JERUSALEM, G., MOONEN, M., FRERES, P., & LANCELLOTTI, P. (2015). The European Association of Cardiovascular Imaging/Heart Faiture Association Cardiac Oncology Toxicity Registry : long-term benefits for breast cancer treatment. Future Oncology, 11 (20), 2791-2794. doi:10.2217/fon.15.227
Peer Reviewed verified by ORBi

Bovy, N., Blomme, B., Freres, P., Dederen, S., Nivelles, O., Lion, M., Carnet, O., Martial, J., Noël, A., Thiry, M., Jerusalem, G., Josse, C., Bours, V., Tabruyn, S., & Struman, I. (2015). Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget. doi:10.18632/oncotarget.3520
Peer Reviewed verified by ORBi

JERUSALEM, G., COLLIGNON, J., Josse, C., SCHROEDER, H., RORIVE, A., FRERES, P., LAMBERT, F., KOOPMANSCH, B., PONCIN, A., & BOURS, V. (2015). Cancer du sein : de la thérapie ciblée à la médecine personnalisée. Revue Médicale de Liège, 70 (5-6), 269-276.
Peer reviewed

FRERES, P., GONNE, E., COLLIGNON, J., GIOT, J.-B., GENNIGENS, C., & JERUSALEM, G. (2015). Prise en charge de la neutropénie fébrile chez le patient cancéreux. Revue Médicale de Liège, 70 (4), 195-200.
Peer reviewed

FRERES, P., JOSSE, C., Bovy, N., Boukerroucha, M., Struman, I., BOURS, V., & JERUSALEM, G. (2014). Neoadjuvant chemotherapy in breast cancer induces miR-34a and miR-122 expression. Journal of Cellular Physiology. doi:10.1002/jcp.24730
Peer Reviewed verified by ORBi

FRERES, P. (19 May 2014). Neoadjuvant chemotherapy in breast cancer patients induces expression of tumor suppressor miR-34a [Poster presentation]. GIGA Cancer Day, Liège, Belgium.

FRERES, P. (24 April 2014). Circulating microRNAs as diagnostic markers in breast cancer patients and their deregulation under neoadjuvant chemotherapy [Poster presentation]. Belgian Medical Genomics Initiative Annual Meeting 2014, Liège, Belgium.

Wenric, S., Freres, P., Josse, C., Bours, V., & Jerusalem, G. (09 December 2013). A miRNA expression based diagnostic tool for breast cancer using random forests [Poster presentation]. Benelux Bioinformatics Conference 2013.

FRANCHIMONT, D., Freres, P., LEBRUN, F., FASSOTTE, M.-F., & D'Orio, V. (1996). Le cas clinique du mois : syndrome de Moskowitz chez un patient traité par ticlopidine. Revue Médicale de Liège, 51 (3), 214-216.
Peer reviewed

Contact ORBi